Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Key Laboratory of Organ Transplantation, Ministry of Education, Wuhan, China.
Am J Transplant. 2020 Jul;20(7):1891-1895. doi: 10.1111/ajt.15901. Epub 2020 Apr 19.
Coronavirus disease 2019 (COVID-19) pandemic spreads rapidly and may be an increasing challenge for transplant community. Clinical data on COVID-19 infection in transplant population is very limited. Herein we presented the clinical course and outcome of a 50-year-old male post liver transplantation who contracted COVID-19, with subsequent infection of his wife. The process of illness was representative. A therapeutic regime with temporary immunosuppression withdrawal and systemic low-dose corticosteroid as principle was involved in the management of the patient which made him recover from severe COVID-19 pneumonia.
2019 年冠状病毒病（COVID-19）疫情迅速蔓延，可能对移植界构成越来越大的挑战。关于移植人群中 COVID-19 感染的临床数据非常有限。在此，我们介绍了一名 50 岁男性肝移植后感染 COVID-19 及其妻子随后感染的临床过程和转归。该患者的发病过程具有代表性。治疗方案涉及暂时停用免疫抑制剂和全身小剂量皮质类固醇，使他从重症 COVID-19 肺炎中康复。
